Skip to main content
. 2014 Jan 8;289(9):5499–5509. doi: 10.1074/jbc.M113.532143

FIGURE 6.

FIGURE 6.

Activin enhances C4ST1 and serglycin expression in myeloma cells. CAG or RPMI 8226 myeloma cells were treated with recombinant activin (500 ng/ml) overnight and the expression of C4ST1 (A) and serglycin (B) was assessed by real time PCR and normalized to 28 S rRNA levels. Data are from three separate experiments ± S.D. #, p < 0.05 compared with activin-untreated cells.